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EDITORIALLaryngeal  neuromonitoring  in  total  thyroidectomy
for  benign  goiter:  Germany  leads  the  way!
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pSome  15  years  ago,  laryngeal  neuromonitoring  was
introduced  in  thyroid  surgery  with  the  aim  of  reducing
the  risk  of  laryngeal  palsy.  Since  then,  despite  numerous
publications,  no  scientiﬁc  consensus  has  emerged  as  to  its
real  beneﬁt.  Three  recent  studies  from  Germany,  however,
seem  to  us  to  transform  the  status  quo.
The  ﬁrst  of  these  reports  stresses  that,  when  a  laryngeal
neuromonitoring  signal  is  recorded  in  strict  conformity  to
international  guidelines  (neural  transmission  being  checked
and  recorded  from  the  pneumogastric  and  inferior  laryn-
geal  nerve  trunks  ipsilateral  to  the  loboisthmectomy),  this
in  no  way  increases  the  risk  of  unilateral  inferior  laryngeal
palsy,  and  is  predictive  of  normal  ipsilateral  laryngeal  mobil-
ity  in  98  to  99%  of  cases  [1].  These  authors  also  reported
that  89%  of  departments  performing  thyroid  surgery  in  Ger-
many  are  equipped  for  laryngeal  neuromonitoring  [1]:  it  is
used  in  more  than  90%  of  operations  and,  in  the  case  of
benign  goiter,  93%  of  German  surgeons  recommend  abstain-
ing  from  resection  of  the  contralateral  thyroid  lobe  if
neuromonitoring  at  the  end  of  loboisthmectomy  fails  to
detect  a  signal  (signal  loss)  in  the  inferior  laryngeal  nerve
[1].
The  second  paper,  published  in  the  World  Journal  of
Surgery  in  2010,  reports  the  results  of  a  Germany  university
hospital  team  that  has  been  using  laryngeal  neuromoni-
toring  systematically,  with  strict  respect  of  international
guidelines,  in  total  thyroidectomy  for  benign  goiter  since
1998  [2].  In  this  prospective  study  in  a  series  of  more
than  1300  patients,  the  contralateral  lobe  was  resected
only  when  neuromonitoring  at  the  end  of  loboisthmectomy
detected  a  signal  (no  signal  loss)  [2].  The  authors  highlight
the  fact  that  no  cases  of  postoperative  bilateral  laryngeal
palsy  occurred  during  this  experience,  whereas  this  compli-
cation  was  to  be  found  during  the  years  preceding  the
introduction  of  intraoperative  neuromonitoring  [2].
The  third  study  concerned  malpractice  claims  relating
to  post-thyroidectomy  laryngeal  palsy  in  Germany  [3]. In  a
retrospective  study  of  the  outcome  of  litigation  following
thyroid  surgery,  Pr.  Dralle  [3]  notes  that,  since  2007,  the
use  or  non-use  of  laryngeal  neuromonitoring  has  been
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http://dx.doi.org/10.1016/j.anorl.2013.01.001ystematically  an  issue  during  hearings.  In  case  of  bilateral
aryngeal  palsy  following  total  thyroidectomy,  failure  to
mplement  neuromonitoring  in  conformity  with  interna-
ional  guidelines  has  led  to  the  verdict  going  against  the
urgeon  in  three-quarters  of  cases  [3].
It  would  thus  seem  that,  in  benign  thyroid  goiter
urgery,  checking  pneumogastric  and  inferior  laryngeal
erve  conduction  status  at  the  end  of  primary  loboisthmec-
omy  is  the  key  to  deciding  whether  or  not  to  operate  on  the
ontralateral  lobe  in  the  same  surgical  step.  This  attitude
rotects  the  patient  against  the  risk  of  bilateral  laryngeal
alsy,  of  which  the  incidence  in  the  literature  ranges  from
.2%  to  0.8%  [2]  and  which  requires  tracheotomy  in  almost
5%  of  cases  [1].
These  ﬁndings  establish  a  new  standard  for  benign  thyroid
oiter  surgery  in  Europe  [1—3].  In  France,  ofﬁcial  statistics
National  Institute  of  Statistics  and  Economic  Studies:  INSEE)
or  January  1st,  2010  gave  the  adult  population  as  50.4  m.
t  most,  10%  can  expect  to  develop  thyroid  goiter  at  some
oint  during  their  life.  Considering  that  only  a  fraction  of
hese  —  at  a low  estimate,  1%  —  will  undergo  surgery  (for
yperthyroidism,  multiple  and/or  evolutive  nodules,  doubt
n  biopsy,  intrathoracic  location,  or  onset  of  complications),
hen  a simple  calculation  shows  that  the  number  of  victims
f  bilateral  laryngeal  palsy  in  France  will  be  in  the  range
f  1000  to  4000.  It  should  also  be  borne  in  mind,  as  can
e  seen  in  the  pages  of  Responsabilité,  the  Journal  of  the
utuelle  d’Assurance  du  Corps  Sanitaire  Franc¸ais  (French
ealth  professionals’  insurance  cooperative:  MACSF),  that
he  sentences  handed  down  in  case  of  post-thyroidectomy
ilateral  laryngeal  palsy  are  becoming  increasingly  severe.
At  a practical  level,  given  the  above  and  the  French  law
o 2002-303  dated  March  4th,  2002  concerning  ‘‘Patients’
ights  and  Health  System  Quality’’  (Loi  relative  aux  droits
es  malades  et  à  la  qualité  du  système  de  santé), all
atients  scheduled  for  total  thyroidectomy  for  benign
oiter  should  be  informed  as  to  whether  international-
tandard  laryngeal  neuromonitoring  is  to  be  associated  to
urgery  and  as  to  the  new  surgical  strategy  entailed  by
ts  use  or  non-use.  When  laryngeal  neuromonitoring  is  not
served.
3t
s
t
p
N
o
t
c
s
p
s
i
c
b
o
d
e
s
I
t
D
T
c
R
[
[
[02  
o  be  implemented,  the  pre-operative  information  session
hould  weigh  the  risk  of  bilateral  laryngeal  palsy  against
he  increased  morbidity  entailed  by  total  thyroidectomy
erformed  in  two  separate  steps.  We  also  consider  that  our
ational  Scientiﬁc  Society,  in  coordination  with  the  various
ther  French  societies  whose  members  also  perform  benign
hyroid  goiter  surgery,  should  inventory  the  number  of
enters  and  surgeons  who  dispose  of  and  use  international-
tandard  laryngeal  neuromonitoring,  so  as  to  estimate  its
enetration  and  implementation  and  decide  whether  it
hould,  as  in  Germany,  become  part  of  standard  procedures
n  France  and  a  reference  in  complaints  procedures.  The
ost  of  international-standard  laryngeal  neuromonitoring  is
y  no  means  negligible:  the  national  bodies  representing
ur  community  should  liaise  with  the  authorities  without
elay  to  estimate  the  extra  costs  involved  in  this  soon  to  be
xpected  addition  to  the  arsenal  of  benign  thyroid  goiter
urgery  in  France,  so  as  to  ensure  that  National  Health
nsurance  coverage  keeps  pace  with  developments,  even  in
his  time  of  budgetary  restriction.isclosure of interest
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